PET helps differentiate between Alzheimer's, HIV complication

01/19/2012 | Medscape (free registration)

A study published in the Archives of Neurology said PET imaging with carbon 11–labeled Pittsburgh compound B helps distinguish HIV-associated neurocognitive disorder from Alzheimer's disease. In the study, patients with symptomatic Alzheimer's had higher C-PiB uptake. Researchers said there is a need for additional studies to better understand the use of the imaging method in older patients with the HIV-related disorder.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA